Effects of acute liver injury on blood coagulation

Summary.  The mechanisms leading to the hemostatic changes of acute liver injury are poorly understood. To study these further we have assessed coagulation and immune changes in patients with acute paracetamol overdose and compared the results to patients with chronic cirrhosis and normal healthy controls. The results demonstrate that in paracetamol overdose coagulation factors (F)II, V, VII and X were reduced to a similar degree and were significantly lower than FIX and FXI (mean levels 0.28, 0.16, 0.13, 0.19, 0.51 and 0.72 IU mL−1, respectively). In cirrhosis, by contrast, FII, FV, FVII, FIX and FX were equally reduced whilst FXI was lower than the other factors (mean levels 0.64, 0.69, 0.62, 0.60, 0.66 and 0.40 IU mL−1, respectively). FVIII was raised in paracetamol overdose patients but normal in those with cirrhosis (mean levels 1.95 and 1.01 IU mL−1, respectively). Interleukin‐6 and tumor necrosis factor‐α levels were raised in both patient groups, but higher levels were found in paracetamol overdose, compared to cirrhosis. Thrombin‐antithrombin and soluble tissue factor levels were higher in those with acute liver injury but normal in cirrhosis. Antithrombin levels were reduced in both acute liver injury and cirrhosis. From these data we put forward a novel mechanism for the coagulation changes in acute paracetamol induced liver injury. We propose that immune activation leads to tissue factor‐initiated consumption of FII, FV, FVII and FX, but that levels of FIX and FXI are better preserved because antithrombin inhibits the thrombin induced positive feedback loop that activates these latter factors.

[1]  R. Cardigan,et al.  The effect of leucocyte depletion on the quality of fresh‐frozen plasma , 2001, British journal of haematology.

[2]  M. Shima,et al.  Cell Surface Heparan Sulfate Proteoglycans Participate in Factor VIII Catabolism Mediated by Low Density Lipoprotein Receptor-related Protein* , 2001, The Journal of Biological Chemistry.

[3]  A. Chuansumrit,et al.  Combined Fresh Frozen Plasma with Recombinant Factor VIIa in Restoring Hemostasis for Invasive Procedures in Children with Liver Diseases , 2001, Thrombosis and Haemostasis.

[4]  A. Burroughs,et al.  Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? , 1999, American Journal of Gastroenterology.

[5]  A. Burroughs,et al.  Original ContributionsDisseminated intravascular coagulation in liver cirrhosis: fact or fiction? , 1999 .

[6]  K. Simpson Cytokines, for better or worse? , 1999, European journal of gastroenterology & hepatology.

[7]  E. Waller,et al.  Expression of Factor VIII by Murine Liver Sinusoidal Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[8]  M. Sallese,et al.  Enhanced expression of monocyte tissue factor in patients with liver cirrhosis , 1998, Gut.

[9]  F. Neumann,et al.  Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[10]  R. Williams,et al.  The management of abnormalities of hemostasis in acute liver failure. , 1996, Seminars in liver disease.

[11]  R. Wilson,et al.  Role of proinflammatory cytokines in acetaminophen hepatotoxicity. , 1995, Toxicology and applied pharmacology.

[12]  N. Mackman,et al.  Transcriptional regulation of tissue factor expression in human endothelial cells. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[13]  A. Thomson,et al.  Circulating proinflammatory cytokines (IL‐1β, TNF‐α, and IL‐6) and IL‐1 receptor antagonist (IL‐1Ra) in fulminant hepatic failure and acute hepatitis , 1994 .

[14]  A. Forbes,et al.  Thrombin—antithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome , 1990, European journal of clinical investigation.

[15]  P. Tracy,et al.  Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. , 1990, The Journal of biological chemistry.

[16]  D D Monkovic,et al.  Activation of human factor V by factor Xa and thrombin. , 1990, Biochemistry.

[17]  R Williams,et al.  Early indicators of prognosis in fulminant hepatic failure. , 1989, Gastroenterology.

[18]  W. Fiers,et al.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Roger Williams,et al.  Increased Factor VIII Complex in Fulminant Hepatic Failure , 1985, Thrombosis and Haemostasis.

[20]  B. Osterud,et al.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. Gazzard,et al.  The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsy. , 1975, Gut.

[22]  B. Gazzard,et al.  Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. , 1975, Gut.

[23]  L. Poller,et al.  Coagulation Studies as a Prognostic Index in Acute Liver Failure , 1975, British journal of haematology.

[24]  B. Gazzard,et al.  A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis , 1974, Gut.

[25]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .

[26]  D. Stirling,et al.  Transcriptional Activation of the Factor VIII Gene in Liver Cell Lines by Interleukin-6 , 1998, Thrombosis and Haemostasis.

[27]  J. Freedman,et al.  Control Mechanisms in Thrombin Generation , 1996, Seminars in thrombosis and hemostasis.

[28]  A. Thomson,et al.  Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. , 1994, Clinical and experimental immunology.

[29]  A. Forbes,et al.  Controlled trial of antithrombin III supplementation in fulminant hepatic failure. , 1993, Journal of hepatology.

[30]  F. Duckert Behaviour of antithrombin 3 in liver disease. , 1973, Scandinavian journal of gastroenterology. Supplement.

[31]  P. Straub Intravascular coagulation in acute hepatic necrosis. , 1970, Lancet.